Active Young, Healthy Mind. The YoungFitT Project
NCT06406283, Not applicable, Unknown, University of Barcelona
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Active Young, Healthy Mind. The YoungFitT Project | ClinicalTrials.gov |
| NCT number | NCT06406283 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 219 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | University of Barcelona | ClinicalTrials.gov |
| Conditions | University Students | ClinicalTrials.gov |
| Interventions | High-Intensity Functional Training (HIFT), Mindfulness-Based Stress Reduction Program (MBSR), Qigong | ClinicalTrials.gov |
| First posted | 2024-05-09 | ClinicalTrials.gov |
| Last updated | 2024-05-09 | ClinicalTrials.gov |
Registered outcomes 35
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Changes in immediate verbal attention | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Direct Digit Span, subtest from the Wechsler Adult Intelligence Scale - Third Edition (WAIS-III). Span. Direct score. Range 0-9. Higher scores indicate better performance. | ClinicalTrials.gov |
| Primary | Changes in processing speed | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Symbol-Digit Coding subtest from the Wechsler Adult Intelligence Scale - Third Edition (WAIS-III). Direct score. Range 0-133. Higher scores indicate better performance. | ClinicalTrials.gov |
| Primary | Changes in visual attention | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Trail Making Test Part A. Seconds to complete the numerical sequence. Direct score. More time indicates worse performance. | ClinicalTrials.gov |
| Primary | Changes in verbal memory | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Rey Auditory Verbal Learning Test. Direct score. Range 0-75. Higher scores indicate better performance. | ClinicalTrials.gov |
| Primary | Changes in visual memory | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Rey-Osterrieth Complex Figure. The memory drawing accuracy at 3-5 minutes. Direct score. Range 0-36. Higher scores indicate better performance. | ClinicalTrials.gov |
| Primary | Changes in Executive Function - Flexibility | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Trail Making Test Part B. Seconds to complete the alphanumeric sequence. Direct score. More time indicates worse performance. | ClinicalTrials.gov |
| Primary | Changes in Executive Function - Inhibition | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Stroop Color and Word Test. Interference of the Stroop Color and Word Test. Interference is calculated as follows: CW - ((W \* C) / (W + C)). Higher scores indicate better performance. Negative values are possible, meaning a bad performance. | ClinicalTrials.gov |
| Primary | Changes in Executive Function - Verbal Fluency | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Phonetic Fluency is measured using the Controlled Oral Word Association Test, spanish adaptation, and semantic fluency test using the category Animal. The total number of evoked words starting with the letters P, M, and R (60 seconds for each letter) and animals (60 seconds). Direct score. Higher scores indicate better performance. | ClinicalTrials.gov |
| Primary | Change in verbal digit working memory | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Backward Digit Span subtest from the Wechsler Adult Intelligence Scale - Third Edition (WAIS-III). Span. Direct score. Range 0-8. Higher scores indicate better performance. | ClinicalTrials.gov |
| Primary | Changes in Verbal Comprehension | Baseline (2 weeks before) | Vocabulary subtest from the Wechsler Adult Intelligence Scale - Third Edition (WAIS-III). Direct score. Range 0-66. Higher scores indicate better performance. | ClinicalTrials.gov |
| Primary | Changes in Psychological symptoms | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | 90 Symptoms Inventory (90-SCL-R). Direct scores from 0 to 4. Higher scores indicate more symptomatology. | ClinicalTrials.gov |
| Primary | Changes in Self-esteem | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Rosenberg Self-esteem scale (RSE). Direct scores from 10 to 40. Higher scores indicate higher self-esteem. | ClinicalTrials.gov |
| Primary | Changes in Depression, anxiety and stress | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Depression, Anxiety and Stress Scale-21 (DASS-21). Direct score. Range 0-126. Higher scores indicate more global symptoms | ClinicalTrials.gov |
| Primary | Changes in Mindfulness | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Five facet mindfulness questionnaire (FFMQ). Direct scores from 39 to 195. Higher scores indicate more Mindfulness levels. | ClinicalTrials.gov |
| Primary | Changes in Self-efficacy | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | General self-efficacy scale (GSE). Direct scores from 10 to 40. Higher scores indicate more self-eficacy. | ClinicalTrials.gov |
| Primary | Changes in Sleep quality | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Pittsburgh Sleep Quality Index (PSQI). Direct score. Range 0-21. Lower scores indicate better sleep quality. | ClinicalTrials.gov |
| Primary | Changes in Diet | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Mediterranean Diet Assessment Tool (PREDIMED). Direct score. Range 0-14. Higher scores indicate more adherence to a Mediterranean diet. | ClinicalTrials.gov |
| Secondary | Changes in Physical activity | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | International Physical Activity Questionnaire (IPAQ). Total physical activity measured in MET-min/week through the International Physical Activity Questionnaire - Short Form. Direct score. Higher scores indicate more physical activity. | ClinicalTrials.gov |
| Secondary | Changes in Anthropometric Measurements - Height | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Height in meters | ClinicalTrials.gov |
| Secondary | Changes in Anthropometric Measurements - Weight | Baseline (2 weeks before) & follow-up (2 weeks after completing interventions) | Weight in Kg | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 40748900 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 9
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Category Fluency | Primary outcome | ConductCognition |
| Complex Figure Copy and Recall | Primary outcome | ConductCognition |
| Digit Span Test | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Trail Making Test A | Primary outcome | ConductCognition |
| Trail Making Test B | Primary outcome | ConductCognition |
| Verbal Fluency | Primary outcome | ConductCognition |
| Verbal Learning | Primary outcome | ConductCognition |
| Vocabulary Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)